Related Experiment Video
Updated: May 28, 2026
Rapid Molecular Detection and Differentiation of Influenza Viruses A and B
Published on: January 30, 2017
MF59™-adjuvanted seasonal influenza vaccine in young children
Joan Puig-Barberà1, Silvia Pérez-Vilar, Javier Díez-Domingo
1Centro Superior de Investigación en Salud Pública, Centre for Public Health Research, Area of Vaccines Research, Avda Cataluña, 21, 46020 Valencia, Spain. jpuigb@terra.es
Insights
Influenza significantly impacts children, necessitating improved prevention. MF59™-adjuvanted vaccines show promise for pediatric influenza immunization, offering better safety and efficacy than traditional options.
Area of Science:
- Pediatrics
- Immunology
- Public Health
Background:
- Influenza causes significant seasonal morbidity and mortality.
- Childhood influenza presents a substantial health burden, comparable to or exceeding that in the elderly.
- Children are key drivers of influenza transmission within communities.
Purpose of the Study:
- To evaluate influenza prevention strategies in children.
- To assess the efficacy and safety of MF59™-adjuvanted influenza vaccines in pediatric populations.
- To address limitations of existing influenza vaccines for young children.
Main Methods:
- Review of surveillance data and diagnostic tools for pediatric influenza.
- Analysis of vaccine performance (efficacy and safety) in children under two years.
- Comparison of inactivated influenza vaccines, live-attenuated influenza vaccines, and MF59™-adjuvanted vaccines.
Main Results:
- Young children experience high influenza-related morbidity.
- Traditional inactivated influenza vaccines are less effective in the very young.
- Live-attenuated influenza vaccines show efficacy but have safety concerns in infants.
- MF59™-adjuvanted vaccines demonstrate a promising safety and efficacy profile in children.
Conclusions:
- Children are a critical target group for influenza prevention efforts.
- MF59™-adjuvanted influenza vaccines offer a potentially superior option for pediatric immunization.
- Targeting children for vaccination may reduce community-wide influenza spread and impact.
Abstract:
Influenza is a viral disease of the upper respiratory tract, which is manifested in seasonal epidemic waves associated with excess morbidity and mortality. Although efforts at prevention have traditionally been focused on the elderly, interest is growing on the specific features of influenza disease in children and the opportunities for prevention in this age group. Owing to recent improvements in surveillance schemes and diagnostic tools it has been realized that young children experience a burden of morbidity due to influenza as high or higher than the elderly and that children possibly act as a source of influenza infection and determinants of the intensity and the spread of influenza in the community, and as a result, the proposition that children should be preferentially targeted for influenza vaccination is gaining acceptance in many industrialized countries. Traditional seasonal inactivated influenza vaccines have performed poorly in the very young and the live-attenuated influenza vaccines, which are highly efficacious in this age group, have been associated with a poor safety profile in those less than 2 years of age. MF59™-adjuvanted influenza vaccines that were traditionally used in the elderly show a very promising safety and efficacy profile in the pediatric population that could overcome the limitations of the other currently available influenza vaccines for use in this age group.
Related Concept Videos
01:27Influenza
01:29Respiratory Syncytial Virus Disease
01:51Vaccinations
01:29Drug Dosing: Infants and Children
01:30Acute Pharyngitis
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
01:28Diphtheria